{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T17:06:36Z","timestamp":1787504796417,"version":"build-2736575974"},"reference-count":41,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["academicradiology.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Academic Radiology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.acra.2022.03.027","type":"journal-article","created":{"date-parts":[[2022,6,6]],"date-time":"2022-06-06T07:35:33Z","timestamp":1654500933000},"page":"30-39","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Safety and Feasibility of Contrast-Enhanced Computed Tomography with a Nanoparticle Contrast Agent for Evaluation of Diethylnitrosamine-Induced Liver Tumors in a Rat Model"],"prefix":"10.1016","volume":"30","author":[{"given":"Takehito","family":"Nota","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Kageyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kakehashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Jogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Etsuji","family":"Sohgawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Murai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoyuki","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Miki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acra.2022.03.027_bib0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.ymeth.2009.08.007","article-title":"Application of micro-CT in small animal imaging","volume":"50","author":"Schambach","year":"2010","journal-title":"Methods"},{"key":"10.1016\/j.acra.2022.03.027_bib0002","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafenib in advanced hepatocellular carcinoma","volume":"359","author":"Llovet","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acra.2022.03.027_bib0003","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0140-6736(18)30207-1","article-title":"Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial","volume":"391","author":"Kudo","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.acra.2022.03.027_bib0004","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.acra.2022.03.027_bib0005","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/hep.23181","article-title":"Radiofrequency ablation of hepatocellular carcinoma: long-term results and prognostic factors in 235 Western patients with cirrhosis","volume":"50","author":"N'Kontchou","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.acra.2022.03.027_bib0006","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ejrad.2013.12.015","article-title":"Percutaneous microwave ablation for hepatocellular carcinoma adjacent to large vessels: a long-term follow-up","volume":"83","author":"Huang","year":"2014","journal-title":"Eur J Radiol"},{"key":"10.1016\/j.acra.2022.03.027_bib0007","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1148\/radiol.2017161413","article-title":"Safety and efficacy of irreversible electroporation for the treatment of hepatocellular carcinoma not amenable to thermal ablation techniques: A retrospective single-center case series","volume":"284","author":"Sutter","year":"2017","journal-title":"Radiology"},{"key":"10.1016\/j.acra.2022.03.027_bib0008","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ymeth.2009.05.016","article-title":"In vivo micro-CT imaging of liver lesions in small animal models","volume":"50","author":"Martiniova","year":"2010","journal-title":"Methods"},{"key":"10.1016\/j.acra.2022.03.027_bib0009","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jvir.2015.02.006","article-title":"Segmental transarterial embolization in a translational rat model of hepatocellular carcinoma","volume":"26","author":"Gade","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2022.03.027_bib0010","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1097\/01.sla.0000218093.12408.0f","article-title":"Marginal hepatectomy in the rat from anatomy to surgery","volume":"244","author":"Madrahimov","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/j.acra.2022.03.027_bib0011","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jvir.2017.03.037","article-title":"Relative initial weight is associated with improved survival without altering tumor latency in a translational rat model of diethylnitrosamine-induced hepatocellular carcinoma and transarterial embolization","volume":"28","author":"Kiefer","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.acra.2022.03.027_bib0012","first-page":"3761","article-title":"Factors impacting technical success rate of image-guided intra-arterial therapy in rat orthotopic liver tumor model","volume":"11","author":"Nishiofuku","year":"2019","journal-title":"Am J Transl Res"},{"key":"10.1016\/j.acra.2022.03.027_bib0013","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/science.152.3718.83","article-title":"Liver carcinogenesis by diethylnitrosamine in the rat","volume":"152","author":"Rajewsky","year":"1966","journal-title":"Science"},{"key":"10.1016\/j.acra.2022.03.027_bib0014","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/toxsci\/kfq307","article-title":"Mitochondrial prohibitins and septin 9 are implicated in the onset of rat hepatocarcinogenesis","volume":"119","author":"Kakehashi","year":"2011","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.acra.2022.03.027_bib0015","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00432-017-2364-z","article-title":"Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine","volume":"143","author":"Ding","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/j.acra.2022.03.027_bib0016","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12906-017-1926-6","article-title":"Anti-cancer effects of Ajwa dates (Phoenix dactylifera L) in diethylnitrosamine induced hepatocellular carcinoma in Wistar rats","volume":"17","author":"Khan","year":"2017","journal-title":"BMC Complementary and Alternative Medicine"},{"key":"10.1016\/j.acra.2022.03.027_bib0017","doi-asserted-by":"crossref","first-page":"e25692","DOI":"10.1371\/journal.pone.0025692","article-title":"Micro-CT based experimental liver imaging using a nanoparticulate contrast agent longitudinal study in mice","volume":"6","author":"Boll","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.acra.2022.03.027_bib0018","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1073\/pnas.90.5.2065","article-title":"Trans-activation of glutathione transferase P gene during chemical hepatocarcinogenesis of the rat","volume":"90","author":"Morimura","year":"1993","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.acra.2022.03.027_bib0019","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1042\/bj2910641","article-title":"Constitutive and inducible profile of glutathione S-transferase subunits in biliary epithelial cells and hepatocytes isolated from rat liver","volume":"291","author":"Parola","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.acra.2022.03.027_bib0020","unstructured":"Rasband WS, Image J, U. S. National Institutes of Health, Bethesda, Maryland, USA, Available at: https:\/\/imagej.nih.gov\/ij, ImageJ version 1.53e, 16 September 2020."},{"key":"10.1016\/j.acra.2022.03.027_bib0021","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nmeth.2089","article-title":"\"NIH Image to ImageJ: 25 years of image analysis\"","volume":"9","author":"Schneider","year":"2012","journal-title":"Nature Methods"},{"key":"10.1016\/j.acra.2022.03.027_bib0022","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.acra.2013.06.003","article-title":"A Comparative analysis of water-soluble and blood-pool contrast agents for in vivo vascular imaging with micro-CT","volume":"20","author":"Nebuloni","year":"2013","journal-title":"Acad Radiol"},{"key":"10.1016\/j.acra.2022.03.027_bib0023","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.acra.2013.06.002","article-title":"Comparison of Fenestra LC, ExiTron nano 6000, and ExiTron nano 12000 for micro-CT imaging of liver and spleen in mice","volume":"20","author":"Boll","year":"2013","journal-title":"Acad Radiol"},{"key":"10.1016\/j.acra.2022.03.027_bib0024","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-017-1247-z","article-title":"Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis","volume":"15","author":"Kageyama","year":"2017","journal-title":"J Transl Med"},{"key":"10.1016\/j.acra.2022.03.027_bib0025","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.21873\/anticanres.14234","article-title":"Establishment of a liver transplant patient-derived tumor xenograft (PDX) model using cryopreserved pancreatic ductal adenocarcinoma","volume":"40","author":"Tanaka","year":"2020","journal-title":"Anticancer Res"},{"key":"10.1016\/j.acra.2022.03.027_bib0026","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12967-020-02377-x","article-title":"Development and optimization of orthotopic liver metastasis xenograft mouse models in uveal melanoma","volume":"18","author":"Sugase","year":"2020","journal-title":"J Transl Med"},{"key":"10.1016\/j.acra.2022.03.027_bib0027","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11307-015-0890-0","article-title":"A comparison of microCT and microPET for evaluating lymph node metastasis in a rat model","volume":"18","author":"Flechsig","year":"2016","journal-title":"Mol Imaging and Biol"},{"key":"10.1016\/j.acra.2022.03.027_bib0028","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1002\/adma.201300081","article-title":"Nano-sized CT contrast agents","volume":"25","author":"Lee","year":"2013","journal-title":"Adv Mater"},{"key":"10.1016\/j.acra.2022.03.027_bib0029","doi-asserted-by":"crossref","first-page":"6249","DOI":"10.1016\/j.biomaterials.2010.04.066","article-title":"Iodinated blood pool contrast media for preclinical X-ray imaging applications\u2013a review","volume":"31","author":"Hallouard","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.acra.2022.03.027_bib0030","doi-asserted-by":"crossref","first-page":"180","DOI":"10.2165\/00003088-199732030-00002","article-title":"An overview of the clinical pharmacokinetics of x-ray contrast media","volume":"32","author":"Bourin","year":"1997","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.acra.2022.03.027_bib0031","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/cmmi.1689","article-title":"Comparison of small animal CT contrast agents","volume":"11","author":"Mannheim","year":"2016","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.acra.2022.03.027_bib0032","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.vascn.2019.02.003","article-title":"Nanoparticle contrast-enhanced micro-CT: A preclinical tool for the 3D imaging of liver and spleen in longitudinal mouse studies","volume":"96","author":"Liu","year":"2019","journal-title":"J Pharmacol Toxicol Methods"},{"key":"10.1016\/j.acra.2022.03.027_bib0033","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.acra.2014.07.022","article-title":"Time course of contrast enhancement by micro-CT with dedicated contrast agents in normal mice and mice with hepatocellular carcinoma: comparison of one iodinated and two nanoparticle-based agents","volume":"22","author":"Rothe","year":"2015","journal-title":"Acad Radiol"},{"key":"10.1016\/j.acra.2022.03.027_bib0034","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s11010-008-9876-4","article-title":"Antiproliferative potential of gallic acid against diethylnitrosamine-induced rat hepatocellular carcinoma","volume":"319","author":"Jagan","year":"2008","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.acra.2022.03.027_bib0035","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1007\/s00330-016-4505-1","article-title":"Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model","volume":"27","author":"Zhang","year":"2017","journal-title":"Eur Radiol"},{"key":"10.1016\/j.acra.2022.03.027_bib0036","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/hep.20538","article-title":"Gefitinib, an EGFR Inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis","volume":"41","author":"Schiffer","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.acra.2022.03.027_bib0037","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.taap.2009.04.018","article-title":"Cytokeratin 8\/18 overexpression and complex formation as an indicator of GST-P positive foci transformation into hepatocellular carcinomas","volume":"238","author":"Kakehashi","year":"2009","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/j.acra.2022.03.027_bib0038","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/cmmi.1551","article-title":"Nanoparticle contrast agents for computed tomography: a focus on micelles","volume":"9","author":"Cormode","year":"2014","journal-title":"Contrast Media Mol Imaging"},{"key":"10.1016\/j.acra.2022.03.027_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0150085","article-title":"In vivo quantitative microcomputed tomographic analysis of vasculature and organs in a normal and diseased mouse model","volume":"11","author":"Das","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.acra.2022.03.027_bib0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.acra.2019.09.020","article-title":"Measurement reliability and diagnostic accuracy of virtual monoenergetic dual-energy CT in patients with colorectal liver metastases","volume":"27","author":"Lenga","year":"2020","journal-title":"Acad Radiol"},{"key":"10.1016\/j.acra.2022.03.027_bib0041","article-title":"Quantitative evaluation of nonalcoholic fatty liver in rat by material decomposition techniques using rapid-switching dual energy CT","author":"Cao","year":"2021","journal-title":"Acad Radiol"}],"container-title":["Academic Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633222002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1076633222002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T08:56:28Z","timestamp":1761036988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1076633222002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1076633222002045"],"URL":"https:\/\/doi.org\/10.1016\/j.acra.2022.03.027","relation":{},"ISSN":["1076-6332"],"issn-type":[{"value":"1076-6332","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and Feasibility of Contrast-Enhanced Computed Tomography with a Nanoparticle Contrast Agent for Evaluation of Diethylnitrosamine-Induced Liver Tumors in a Rat Model","name":"articletitle","label":"Article Title"},{"value":"Academic Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acra.2022.03.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Inc. on behalf of The Association of University Radiologists.","name":"copyright","label":"Copyright"}]}}